trial
as of 2026-07-01Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
NCTId NCT00802100
at a glance
Phase 4 · Completed
Enrollment 21 (actual)
Sponsored by National Institute of Mental Health (NIMH)
Primary completion 2009-09
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
21 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2008-12
Primary completion
2009-09
Eligibility
ALL · 18 Years · 40 Years
Interventions & indications
Sponsors
National Institute of Mental Health (NIMH)Lead Sponsor
Investigators
3
Marvin Swartz, MDPrincipal Investigator
T. Scott Stroup, MD, MPHPrincipal Investigator
Joseph P. McEvoy, MDPrincipal Investigator
Sites
13 total
Colton, United StatesPalo Alto, United StatesNew Haven, United StatesMiami, United StatesAugusta, United StatesGlen Burnie, United StatesWorcester, United StatesDetroit, United StatesMinneapolis, United StatesNew York, United StatesButner, United StatesDallas, United States
Facts & assertions
4 sourced
Enrollment
21
Phase
PHASE4
Primary Completion Date
2009-09
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
indication
investigator